EDCTP portfolio: Tuberculosis

25 grants
€146.73 M


Collaborative clinical studies and clinical trials

EDCTP portfolio: Tuberculosis


25 grants
€146.73 M

Note: A further €26.06M for 24 grants was awarded to projects on nonintervention-specific.

Advancing a suite of TB drug treatments

Treating TB and HIV in neglected groups

Tackling TB and HIV together

Facilitating implementation of TB testing

Shorter treatment for drug-resistant TB

Advancing new options for treatment of TB

Statin use to boost anti-TB therapies

Improving treatments for TB-associated meningitis

A new approach for TB vaccination

Better TB protection for newborns

Building a successor to BCG

About us

The European & Developing Countries Clinical Trials Partnership (EDCTP) is a public–public partnership between 14 European and 16 African countries, supported by the European Union. EDCTP’s vision is to reduce the individual, social and economic burden of poverty-related infectious diseases by affecting sub-Saharan Africa. EDCTP’s mission is to accelerate the development of new or improved medicinal products for the identification, treatment and prevention of infectious diseases, including emerging and re-emerging diseases, through pre- and postregistration clinical studies, with emphasis on phase II and III clinical trials. Our approach integrates conduct of research with development of African clinical research capacity and networking. The second EDCTP programme is implemented by the EDCTP Association supported under Horizon 2020, the European Union’s Framework Programme for Research and Innovation.

Contact us

For more information, please contact us or leave a message using this form.
Please enter your name
Please enter a correct e-mail address
Please enter a comment
Thank you! Your message has been sent.
Something went wrong while submitting the form. Try again.

Share this publication

Forward this page by e-mail or share it directly on social media.


Enter a search term to search the EDCTP publications.
Minimal length to search is 3 characters

This publication uses cookies

We use functional and analytical cookies to improve our website. In addition, third parties place tracking cookies to display personalised advertisements on social media. By clicking accept you consent to the placement of these cookies.